NO974035L - En ny vekstfaktor og en genetisk sekvens som koder for denne - Google Patents

En ny vekstfaktor og en genetisk sekvens som koder for denne

Info

Publication number
NO974035L
NO974035L NO974035A NO974035A NO974035L NO 974035 L NO974035 L NO 974035L NO 974035 A NO974035 A NO 974035A NO 974035 A NO974035 A NO 974035A NO 974035 L NO974035 L NO 974035L
Authority
NO
Norway
Prior art keywords
growth factor
sequence encoding
genetic sequence
new growth
molecule
Prior art date
Application number
NO974035A
Other languages
English (en)
Other versions
NO974035D0 (no
NO320839B1 (no
Inventor
Nicholas Kim Hayward
Gunther Weber
Sean Grimmond
Magnus Nordenskjold
Catharina Larsson
Original Assignee
Amrad Operations Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPN1457A external-priority patent/AUPN145795A0/en
Priority claimed from AUPN6647A external-priority patent/AUPN664795A0/en
Priority claimed from AUPN7274A external-priority patent/AUPN727495A0/en
Application filed by Amrad Operations Pty Ltd filed Critical Amrad Operations Pty Ltd
Publication of NO974035D0 publication Critical patent/NO974035D0/no
Publication of NO974035L publication Critical patent/NO974035L/no
Publication of NO320839B1 publication Critical patent/NO320839B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Physics & Mathematics (AREA)
  • Cardiology (AREA)
  • Neurology (AREA)
  • Plant Pathology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO19974035A 1995-03-02 1997-09-02 Isolert polypeptid, fremgangsmate for dets fremstilling, isolert nukleinsyremolekyl, isolert antistoff, antisensemolekyl, preparat, anvendelse av henholdsvis et polypeptid og et nukleinsyremolekyl, vertscelle samt vektor. NO320839B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPN1457A AUPN145795A0 (en) 1995-03-02 1995-03-02 A novel growth factor and a genetic sequence encoding same
AUPN6647A AUPN664795A0 (en) 1995-11-20 1995-11-20 A novel growth factor and a genetic sequence encoding same
AUPN7274A AUPN727495A0 (en) 1995-12-22 1995-12-22 A novel growth factor and a genetic sequence encoding same-II
PCT/AU1996/000094 WO1996027007A1 (en) 1995-03-02 1996-02-22 A novel growth factor and a genetic sequence encoding same

Publications (3)

Publication Number Publication Date
NO974035D0 NO974035D0 (no) 1997-09-02
NO974035L true NO974035L (no) 1997-11-03
NO320839B1 NO320839B1 (no) 2006-01-30

Family

ID=27157841

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19974035A NO320839B1 (no) 1995-03-02 1997-09-02 Isolert polypeptid, fremgangsmate for dets fremstilling, isolert nukleinsyremolekyl, isolert antistoff, antisensemolekyl, preparat, anvendelse av henholdsvis et polypeptid og et nukleinsyremolekyl, vertscelle samt vektor.

Country Status (15)

Country Link
US (1) US20070135344A1 (no)
EP (1) EP0815221B1 (no)
JP (2) JPH11500139A (no)
KR (1) KR100414615B1 (no)
CN (1) CN1194090C (no)
AT (1) ATE252600T1 (no)
BR (1) BR9607628A (no)
CA (1) CA2214439C (no)
DE (1) DE69630442T2 (no)
ES (1) ES2206558T3 (no)
FI (1) FI120153B (no)
HU (1) HU223438B1 (no)
NO (1) NO320839B1 (no)
NZ (2) NZ337634A (no)
WO (1) WO1996027007A1 (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5928939A (en) * 1995-03-01 1999-07-27 Ludwig Institute For Cancer Research Vascular endothelial growth factor-b and dna coding therefor
EP0873348A4 (en) * 1995-06-06 2000-11-08 Human Genome Sciences Inc HUMAN VASCULAR ENDOTHELIAL GROWTH FACTOR 3
ES2202469T5 (es) 1995-09-08 2011-06-06 Genentech, Inc. Proteína relacionada con el vegf.
WO1997012972A2 (en) 1995-09-29 1997-04-10 Universita'degli Studi Di Siena Regulated genes and uses thereof
US6994989B1 (en) 1995-11-08 2006-02-07 Immunex Corp. FLK-1 binding proteins
AU1116297A (en) 1995-11-08 1997-05-29 Immunex Corporation Flk-1 binding protein
CA2263890C (en) 1996-08-23 2013-05-14 Ludwig Institute For Cancer Research Recombinant vascular endothelial cell growth factor d (vegf-d)
JP2001524828A (ja) * 1997-04-25 2001-12-04 コラテラル・セラピューティクス 切断型ｖｅｇｆ関連蛋白質
EP1053326A2 (en) 1998-02-06 2000-11-22 Collateral Therapeutics Variants of the angiogenic factor vascular endothelial cell growth factor: vegf
US7105481B2 (en) 1998-11-10 2006-09-12 Ludwig Institute For Cancer Research Method for stimulating connective tissue growth or wound healing
JP2002534061A (ja) * 1998-11-10 2002-10-15 ルードヴィッヒ・インスティテュート・フォア・キャンサー・リサーチ 血小板由来増殖因子ｄ、それをコードするｄｎａ、及びその利用法
CA2354325C (en) 1998-12-07 2011-08-16 Zymogenetics, Inc. Growth factor homolog zvegf3
US6783953B1 (en) 1998-12-22 2004-08-31 Janssen Pharmaceutica N.V. Vascular endothelial growth factor-X
AUPQ568100A0 (en) * 2000-02-16 2000-03-09 Amrad Operations Pty. Limited A method for producing recombinant molecules
AU2884102A (en) 2000-12-07 2002-06-18 Sangamo Biosciences Inc Regulation of angiogenesis with zinc finger proteins
US7067317B2 (en) 2000-12-07 2006-06-27 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
US7981863B2 (en) * 2001-09-19 2011-07-19 Neuronova Ab Treatment of Parkinson's disease with PDGF
EP1869075B1 (en) 2005-02-28 2012-04-11 Sangamo BioSciences, Inc. Anti-angiogenic methods and compositions
CN100448892C (zh) * 2006-08-02 2009-01-07 中国人民解放军军事医学科学院基础医学研究所 抗肿瘤血管内皮生长因子受体vegf－r2抗原及其编码基因与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5073492A (en) * 1987-01-09 1991-12-17 The Johns Hopkins University Synergistic composition for endothelial cell growth
US5332671A (en) * 1989-05-12 1994-07-26 Genetech, Inc. Production of vascular endothelial cell growth factor and DNA encoding same
US5219739A (en) * 1989-07-27 1993-06-15 Scios Nova Inc. DNA sequences encoding bVEGF120 and hVEGF121 and methods for the production of bovine and human vascular endothelial cell growth factors, bVEGF120 and hVEGF121
US5194596A (en) * 1989-07-27 1993-03-16 California Biotechnology Inc. Production of vascular endothelial cell growth factor
US5338671A (en) * 1992-10-07 1994-08-16 Eastman Kodak Company DNA amplification with thermostable DNA polymerase and polymerase inhibiting antibody
EP0751992B1 (en) * 1994-03-08 2005-11-09 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
US5607918A (en) * 1995-03-01 1997-03-04 Ludwig Institute For Cancer Research Vascular endothelial growth factor-B and DNA coding therefor
US5928939A (en) * 1995-03-01 1999-07-27 Ludwig Institute For Cancer Research Vascular endothelial growth factor-b and dna coding therefor

Also Published As

Publication number Publication date
HUP9800377A3 (en) 2000-12-28
EP0815221B1 (en) 2003-10-22
BR9607628A (pt) 1999-11-30
CN1224464A (zh) 1999-07-28
WO1996027007A1 (en) 1996-09-06
NO974035D0 (no) 1997-09-02
NZ337634A (en) 2001-06-29
EP0815221A1 (en) 1998-01-07
US20070135344A1 (en) 2007-06-14
CA2214439A1 (en) 1996-09-06
NZ301611A (en) 2000-02-28
FI120153B (fi) 2009-07-15
JPH11500139A (ja) 1999-01-06
NO320839B1 (no) 2006-01-30
CN1194090C (zh) 2005-03-23
JP2001037493A (ja) 2001-02-13
EP0815221A4 (en) 1998-12-09
KR19980702702A (ko) 1998-08-05
FI973571L (fi) 1997-10-30
KR100414615B1 (ko) 2004-05-27
ES2206558T3 (es) 2004-05-16
DE69630442T2 (de) 2004-08-19
FI973571A0 (fi) 1997-09-01
HU223438B1 (hu) 2004-07-28
HUP9800377A1 (hu) 1998-06-29
JP3683778B2 (ja) 2005-08-17
DE69630442D1 (de) 2003-11-27
ATE252600T1 (de) 2003-11-15
CA2214439C (en) 2002-12-17
HK1002963A1 (en) 1998-09-30

Similar Documents

Publication Publication Date Title
NO974035D0 (no) En ny vestfaktor og en genetisk sekvens som koder for denne
ATE189475T1 (de) Wachstums-differenzierungsfaktor der tgf-b familie
ATE389666T1 (de) Hohe expressionsrate von proteinen
NO961812D0 (no) Humanproteaseinhibitorer av Kunitz-type
ATE184613T1 (de) Varianten des grünen fluoreszenzproteins, gfp
ATE310015T1 (de) Hohe expressionsrate des grün-fluoreszierenden proteins
WO1996012021A3 (en) Nematode-extracted serine protease inhibitors and anticoagulant proteins
RU95110871A (ru) Способы определения нуклеотидной последовательности
DK1346034T3 (da) von Willebrand-faktor (vWF) spaltende protease-polypeptid, nukleinsyre kodende for polypeptidet og anvendelse af polypeptidet
HRP20010036B1 (hr) Neurotrofni faktor rasta
ATE370159T1 (de) Streptavidin-bindungspeptid
FI972384L (fi) Uudet dipeptidiset p-amidinobentsyyliamidit, jotka sisältävät N-terminaalisia sulfonyyli- tai amidinosulfonyyliryhmiä
WO2002060917A3 (en) Method to treat hemophilia
DK0719328T3 (da) Genet GRB 3-3, varianter deraf og anvendelse deraf
ATE285474T1 (de) Haemophilus adhäsionsproteinen
ATE427959T1 (de) Gereinigtes sr-p70 protein
DE69938130D1 (de) Neue peptide
PE20399A1 (es) Muteina ob
DK0540574T3 (da) Antikoagulationspeptider
DE69826029D1 (de) Acetyl-coa-carboxylase von candida albicans
AU5163598A (en) Novel hepatitis b inhibitors
FR2654430B1 (fr) Nouveaux derives de peptides, utilisables comme inhibiteurs des collagenases bacteriennes.
DE60038735D1 (de) Pseudomycin analoge
EA199800028A1 (ru) Винилсульфоксиды и способы их синтеза
SE9302856D0 (sv) Method and means for producing a plasmapeotein-binding protein

Legal Events

Date Code Title Description
MK1K Patent expired